Navigation Links
Obesity raises IVF miscarriage risk

Obese women are far more likely to miscarrry after IVF treatment- but losing even a few kilos could make a huge difference, say doctors.

They are urging overweight women to change their diets, and take excercise, prior to embarking on fertilty treatments.

Obese women have long been known to have problems conceiving naturally, and studies have shown that their overall success rates for IVF do not match those of those with a normal body mass.

The latest research, from Professor Robert Norman's team at the Reproductive Medicine Unit at the Queen Elizabeth Hospital in Adelaide, analysed the way obesity affected the pregnancies of those patients who had managed to conceive with IVF.

The study looked at the progress of a variety of women and compared this with their body mass index(BMI)- their weight in kilos divided height in metres squared.

Women with a BMI of between 30 and 35-obese but not grossly obese had a miscarriage rate after fertility treatment of 27%. Those with a BMI of over 35 miscarried in 34% of the cases.

This equates approximately to 50% increased risk among the lower weight group, and a doubled risk among the most obese patients.

Professor Norman speculated that as the body's ability to deal with insulin properly could be affected by carrying excess weight, this could impact on the supply of blood to the developing placenta.
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity a risk for pancreatic cancer
3. Obesity shortens lifespan
4. Is Obesity a risk factor?
5. Obesity a global problem
6. Obesity increases health costs
7. Obesity in children a risk factor for diabetes
8. Decrease of Hunger Hormone after Obesity Surgery
9. Obesity risk for immobilized adults
10. Obesity risk can be reduced by eating breakfast regularly
11. Reduce watching TV to prevent Obesity and Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Obesity raises IVF miscarriage risk

(Date:5/16/2008)...the aftermath of central China,s,earthquake, up to...s, and,over 150,000 were injured. An estimated 10 ...who have lost their homes. With great sorrow for,t...er Ching Hai donated an,additional US$30,000, for ...eme Master Ching Hai International Association mem...
(Date:5/16/2008)...rathyroid hormone readings, study says , ...f vitamin D and high levels of a hormone secreted ... depression in older adults, according to a new re...issue of Archives of General Psychiatry , support... D, depression and other psychiatric illnesses are...
(Date:5/16/2008)... WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Mor...cians in the Greater Portland, Oregon and,Vancouve...contract as,Teamsters., "The Teamsters are please...ontract that gives them job protection and a secur...dent Jim Hoffa., The workers, both full-time and ...
(Date:5/16/2008)... medicine is in a precipitous decline, David C. Da... Physicians (ACP), today joined with leading repr...call for comprehensive reforms to attract, recruit...are physicians. , During a panel discussion of .... Dale and other panelists spoke about the challen...
Breaking Medicine News(10 mins):Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2
...t the incidence of new diseases and rise in infect...ural environment,// which has led to an imbalance ...crease in livestock production has lead to spread ...bird flu from poultry birds to humans as these vir...
...ure from charities for making it possible to incre...tter than tamoxifen//. Women suffering from the ea...en. If the women who were treated with tamoxifen f...one of the new drugs, they are more likely to be a...
...undergone a further graft on Friday, even as contr...38, in Lyons, France, received a second transplant..., which had been successful, doctors said. This is...iss Dinoire rejecting the face. The technique was ...
...hree leading killers in the U.S., all dropped in 2...o, Americans' life expectancy increased again in 2...it was 75.4 in 1990. Life expectancy in the U.S. ...interruption since 1900, because of several factor...
Other Medicine News:Health News:Face transplant woman has new graft 2Health News:US life expectancy climbs to a new high 2
(Date:5/15/2008)...APPENZELL, Switzerland, May 15 /- Erg... Food and Drug Administration (FDA) has,granted or...nt of pulmonary,arterial hypertension (PAH). Tergu...otal Phase II trial in Europe., "The FDA,s grant ...courages and strengthens our development program b...
(Date:5/15/2008)...BONITA SPRINGS, Fla., May 15 /- Tigri...ion of a Cooperative Research and,Development Agre...NCI) to,collaborate on clinical and preclinical de... Phase I development. AFP-464 is converted to,meta... p53 activation and,apoptosis., This is part of a...
(Date:5/15/2008)...iderable Opportunity Remains for an Antiplatelet T...leeding than the Combination of Plavix/Iscover ...ion Resources, WALTHAM, Mass., May 15 /PRNewswire...g research and advisory firms for pharmaceutical a...i Lilly,s Effient offers,improvement in patient co...
(Date:5/15/2008)...p Line Data Expected soon after CEA Trial data rep... -, SAN FRANCISCO, May 15 /PRNewswire-FirstC..., a biotechnology company focused on the developme...r disease, announced today that,it has completed p...ACS),study. The ACS study is one of three Phase 2 ...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL org 15871 1Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL org 15871 2Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL org 15871 3Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL org 15871 4NCQA Awards Quality Plus Distinction to Blue Cross and Blue Shield of Minnesota for Physician and Hospital Quality Measures 15868 1NCQA Awards Quality Plus Distinction to Blue Cross and Blue Shield of Minnesota for Physician and Hospital Quality Measures 15868 2Comfort C 28R 29 Provides Significantly Higher Absorption Than Other Leading Brand 15865 1Comfort C 28R 29 Provides Significantly Higher Absorption Than Other Leading Brand 15865 2Dendreon Announces 2447 Million Registered Direct Offering 4379 1Dendreon Announces 2447 Million Registered Direct Offering 4379 2Dendreon Announces 2447 Million Registered Direct Offering 4379 3
CenterPointLock Stoma Irrigator Drain
CenterPointLock Pre-Sized FlexWear Skin Barrier, Flat
CenterPointLock Pre-Sized Convex FlexWear Skin Barrier
CenterPointLock Drainable Pouch, Beige
Medicine Products: